Media

Here in the media centre you will find a range of resources including our latest and archived press releases, statements from our CEO, speeches and presentations, information on our social media policy, and our photo and video library.

From our CEO

A selection of videos and publications featuring our CEO Sir Andrew Witty.

Speeches & presentations

Find the latest and archived speeches and presentations from GSK’s senior executives.

Press releases

These press releases are intended for business journalists and analysts/investors.
10 May 2013

BREO™ ELLIPTA™ gains US approval for the treatment of COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO™ ELLIPTA™ as an inhaled long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

09 May 2013

GSK and Save the Children form unique partnership to save the lives of one million children

An ambitious new partnership to save the lives of a million of the poorest children in the world has been launched by GSK and Save the Children.

09 May 2013

GSK enters new commitment with the GAVI Alliance to supply cervical cancer vaccine for girls in the world’s poorest countries

GlaxoSmithKline (GSK) today announced a new commitment to the GAVI Alliance to supply its cervical cancer vaccine as part of a new long term programme to help protect girls against cervical cancer in the world’s poorest countries.

Social media

More about our social media activities

Annual Report 2012

Download the 2012 Annual Report

Information for investors